ThinkSabio

$NIKI

$1.68▲ +5.0% YTD

7 SEC 13D/G filings tracked · Last updated Nov 9, 2026

Filing History
News
NIKI ▲ +5.0% - Niki BioSolutions, Inc.
CP $1.68▲ +5.0%Nov 9, 2026 · ThinkSabio Blog

$NIKI - Niki BioSolutions Announces Presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2026 Conference…

News
NIKI ▲ +10.5% - Niki BioSolutions, Inc.
CP $2.00▲ +10.5%Oct 26, 2026 · ThinkSabio Blog

$NIKI - Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using Dried Blood Spots, Plasma, and Urine…

News
NIKI ▼ -5.4% - Niki BioSolutions, Inc.
CP $1.75▲ -5.4%Oct 23, 2026 · ThinkSabio Blog

$NIKI - Niki BioSolutions Signs Agreement to Supply APOE Genotyping to Charter Research…

News
NIKI ▲ +4.2% - Niki BioSolutions, Inc.
CP $2.74▲ +4.2%Oct 14, 2026 · ThinkSabio Blog

$NIKI - Niki BioSolutions Partners with Global Alzheimer’s Platform Foundation to Deliver Plasma-Based APOE Genotyping for Bio-Hermes-002…

News
NIKI ▲ +3.8% - Niki BioSolutions, Inc.
CP $5.16▲ +3.8%Sep 25, 2026 · ThinkSabio Blog

$NIKI - Niki BioSolutions to Participate in the Lytham Partners Fall 2026 Investor Conference…

News
NIKI ▼ -1.8% - Niki BioSolutions, Inc.
CP $5.61▲ -1.8%Sep 14, 2026 · ThinkSabio Blog

$NIKI - Niki BioSolutions Accelerates Its Alzheimer’s Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership w…

News
NIKI ▼ -3.2% - Niki BioSolutions, Inc.
CP $6.00▲ -3.2%Sep 8, 2026 · ThinkSabio Blog

$NIKI - Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference…